01—Abstract
Summary
Summary of the 8-K filed August 6, 2025. Cited figures are marked; the original filing is the authoritative source.
Corteva (CTVA) reported strong second-quarter and first-half 2025 results on August 6, 2025, and raised its full-year 2025 guidance.
Q2 net sales rose 6% to $6.46 billiona (7% organic), GAAP EPS from continuing operations was $2.02 (up 34%), and Operating EBITDA grew 13% to $2.16 billion, with roughly 215 basis points of margin expansion. Operating EPS was $2.20, up 20%. Growth was led by Crop Protection, where volume rose 11% on new products, fungicides and biologicals, particularly in Latin America, and Seed, where North American corn area and share gains drove a 3% volume increase and 3% price increase.
For the first half, net sales rose 3% to $10.87 billionb (5% organic), Operating EBITDA rose 14% to $3.35 billion, and Operating EPS rose 22% to $3.33. Management raised full-year 2025 guidance to net sales of $17.6-$17.8 billion, Operating EBITDA of $3.75-$3.85 billion, and Operating EPS of $3.00-$3.20, implying roughly 21% Operating EPS growth at the midpoint. The company also plans to repurchase about $1 billion of shares in 2025 and increased its dividend.
Weak spots include Latin America Seed, where sales fell 26%c in Q2 amid just-in-time purchasing in Argentina, and Crop Protection pricing, which declined 2% in the first half on competitive pressure in Latin America. Investors should note that the 8-K furnishes these results under Item 2.02 and that the figures are unaudited press-release data.
Management also expects roughly $150d-$165 million in 2025 restructuring charges tied to the Crop Protection network optimization, and it says it does not expect a material net impact from tariffs under current policies. The filing contains a meaningful amount of non-GAAP adjustment, so GAAP and operating metrics should be considered together.
02—Key points
Key Highlights
- Q2 2025 net sales rose 6% to $6.46B (7% organic), with Crop Protection volume up 11% and Seed volume up 3%.
- Q2 GAAP EPS from continuing operations was $2.02, up 34% year over year; Operating EPS was $2.20, up 20%.
- Q2 Operating EBITDA reached $2.16B, up 13%, with about 215 bps of margin expansion; Seed EBITDA rose 10% and Crop Protection EBITDA rose 31%.
- Full-year 2025 guidance raised: net sales $17.6-$17.8B, Operating EBITDA $3.75-$3.85B, Operating EPS $3.00-$3.20.
- Capital returns: plans to repurchase about $1.0B of shares in 2025 and increased its dividend, supported by a strong balance sheet and cash flow.
- Risk areas: Latin America Seed sales fell 26% in Q2 and Crop Protection price declined 2% in 1H on competitive pressure in Latin America.
- Expected 2025 restructuring charges of roughly $150-$165M pre-tax tied to Crop Protection manufacturing and partner network optimization.
03—Questions
Frequently Asked Questions
What drove Corteva's strong second-quarter 2025 performance?
Growth came from higher Crop Protection volume (up 11%), led by Latin America demand for new products, fungicides, spinosyns and biologicals, and from Seed volume (up 3%) on North American corn area gains and share gains. Cost discipline, raw material deflation and productivity savings lifted Operating EBITDA margins by about 215 bps.
Why did Corteva raise its full-year 2025 guidance?
The company cited strong first-half results that exceeded expectations, incremental benefits from controllable cost levers, and growth platforms. It also pointed to expected second-half growth, particularly in Latin America, and confidence in its 2027 financial framework.
What are the main weak spots investors should watch?
Latin America Seed sales fell 26% in Q2 due to just-in-time purchasing in Argentina that shifted sales to the second half. Crop Protection pricing remains under pressure, with prices down 2% in 1H on competitive dynamics in Latin America. Management expects a flattish market in which volume gains are offset by pricing headwinds.
Is Corteva returning capital to shareholders?
Yes. Corteva expects to repurchase about $1.0 billion of shares in 2025 and increased its dividend. Through the first half, it had already spent $520 million on share repurchases and paid $232 million in dividends.
Do the tariff and macro environments pose a material risk to 2025 results?
Management said it does not expect a material net impact from ongoing tariff negotiations based on policies in place today, and it expects global grain and oilseed demand not to decline regardless of trade flow changes. The company still describes the macro environment as fluid, and grain prices have been pressured by expectations of a large 2025 harvest.
04—Continue